Invoking Yogi Berra, Gilead Ruling Requires Clear Patent Steps

Ashley Moore, Office Managing Partner at M&R Dallas, was quoted extensively in a recent article published by Bloomberg Law titled, “Invoking Yogi Berra, Gilead Ruling Requires Clear Patent Steps.” Ashley commented on a recent Federal Circuit ruling that cancelled a patent for a drug to treat Hepatitis C. More specifically, she discussed how the case demonstrates the need for drug companies to clearly connect their extensive research and development to later patents to ensure their creations’ IP protections.